Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Diane J. Aschman"'
Autor:
Jill M. Johnsen, Shelley N. Fletcher, Haley Huston, Sarah Roberge, Beth K. Martin, Martin Kircher, Neil C. Josephson, Jay Shendure, Sarah Ruuska, Marion A. Koerper, Jaime Morales, Glenn F. Pierce, Diane J. Aschman, Barbara A. Konkle
Publikováno v:
Blood Advances, Vol 1, Iss 13, Pp 824-834 (2017)
Abstract: Hemophilia A and B are rare, X-linked bleeding disorders. My Life, Our Future (MLOF) is a collaborative project established to genotype and study hemophilia. Patients were enrolled at US hemophilia treatment centers (HTCs). Genotyping was p
Externí odkaz:
https://doaj.org/article/5eead2a944f548ea9aa455c5466a5ad6
Autor:
Joanna A. Davis, Allison P. Wheeler, J. Sanders, Shannon L. Carpenter, Ming Y. Lim, James French, Steven W. Pipe, Amit Soni, Michael D. Tarantino, Dunlei Cheng, Amy D. Shapiro, C. Knoll, Ralph A. Gruppo, Catherine E. McGuinn, Amy L. Dunn, Sanjay P Ahuja, Robert F. Sidonio, Dagmar Stein, Ruchika Sharma, Diane J. Aschman, Guy Young
Publikováno v:
Haemophilia. 23:e385-e388
Autor:
Barbara A. Konkle, Glenn F. Pierce, Haley Huston, Marion A. Koerper, Martin Kircher, Sarah Ruuska, Jay Shendure, Beth Martin, Sarah Roberge, Shelley N Fletcher, Jill M. Johnsen, Diane J. Aschman, Jaime Morales, Neil C Josephson
Publikováno v:
Blood Advances. 1:824-834
Hemophilia A and B are rare, X-linked bleeding disorders. My Life, Our Future (MLOF) is a collaborative project established to genotype and study hemophilia. Patients were enrolled at US hemophilia treatment centers (HTCs). Genotyping was performed c
Autor:
Mariam Voutsis, Meredith Oakley, Becky Dudley, Steven Humes, Michael Recht, Marilyn J. Manco-Johnson, Vanessa R. Byams, Suzanne Kapica, Diane J. Aschman, Brandi Dupervil, Althea M. Grant, Roshni Kulkarni
Publikováno v:
American Journal of Hematology. 93
Autor:
K. M. Mclaughlin, Diane J. Aschman, Guy Young, Regina Butler, S. Senter, Ann D. Forsberg, Sanjay P Ahuja, A. Cheadle, Brenda Riske
Publikováno v:
Haemophilia. 22:e11-e17
Aim The National Hemophilia Program Coordinating Center, with the U.S. Regional Hemophilia Network conducted a national needs assessment of U.S. Hemophilia Treatment Center (HTC) patients. The objectives were to determine: (i) To what extent do patie
Autor:
Connie H. Miller, J. Michael Soucie, Fiona M. Kelly, Donna DiMichele, Barbara A. Konkle, Roshni Kulkarni, Diane J. Aschman, Paul E. Monahan
Publikováno v:
American Journal of Hematology. 89:621-625
On March 12, 2012, the Centers for Disease Control and Prevention (CDC) held a meeting of its partners in hemophilia treatment, community-based organizations, industry, and government to review data and discuss implementation issues relevant to plann
Autor:
Amy D. Shapiro, Ann D. Forsberg, Roshni Kulkarni, Diane J. Aschman, Thomas C. Abshire, Jeanne M. Lusher
Publikováno v:
American Journal of Preventive Medicine. 41:S332-S337
Specialists in rare disorders often face challenges in collecting surveillance and research data. As movement toward more fully realizing the potential of electronic health information gains momentum, practitioners who treat individuals with rare dis
Publikováno v:
American Journal of Preventive Medicine. 41:S324-S331
Rare coagulation disorders (RCDs) present a considerable and multifaceted public health risk. Although inherited RCDs affect a minor segment of any local healthcare delivery system, their global impact is major and highlight the challenges of deliver
Autor:
Diane J Aschman
Publikováno v:
Health Information Management. 31:17-25
Classification systems are the primary means for automated retrieval and analysis of healthcare data from individual patient medical records. This article will provide a brief history and overview of the two most comprehensive and advanced controlled
Autor:
Sarah Ruuska, Barbara A. Konkle, Glenn F. Pierce, Beth Martin, Marion A. Koerper, Leslie Meltzer, Shelley N Fletcher, Martin Kircher, Jill M. Johnsen, Haley Huston, Neil C Josephson, Sarah Roberge, Jay Shendure, Diane J. Aschman
Publikováno v:
Blood. 128:205-205
Background Hemophilia A and B are rare X-linked bleeding disorders affecting ~1:5000 male births. Hemophilia genotype is important to inform reproductive planning, pregnancy, and neonatal management, risk of inhibitor formation and bleeding severity,